|
|
||||||||
in PTH stimulation of
IGF-binding protein-5 mRNA in UMR-106-01 cells
Department of Pharmacology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
We have investigated the role of protein
kinase C (PKC) signal transduction pathways in parathyroid hormone
(PTH) regulation of insulin-like growth factor-binding protein-5
(IGFBP-5) gene expression in the rat osteoblast-like cell line
UMR-106-01. Involvement of the PKC pathway was determined by the
findings that bisindolylmaleimide I inhibited 40% of the PTH effect,
and 1 µM bovine PTH-(3-34) stimulated a 10-fold induction of
IGFBP-5 mRNA. PTH-(1-34) and PTH-(3-34) (100 nM) both
stimulated PKC-
translocation from the membrane to the nuclear
fraction. Rottlerin, a PKC-
-specific inhibitor, and a dominant
negative mutant of PKC-
were both able to significantly inhibit
PTH-(1-34) and PTH-(3-34) induction of IGFBP-5 mRNA,
suggesting a stimulatory role for PKC-
in the effects of PTH.
Phorbol 12-myristate 13-acetate (PMA) stimulated PKC-
translocation
from the cytosol to the membrane and inhibited ~50% of the
PTH-(1-34), forskolin, and 8-bromoadenosine 3',5'-cyclic monophosphate-stimulated IGFBP-5 mRNA levels, suggesting that PKC-
negatively regulates protein kinase A (PKA)-mediated induction of
IGFBP-5 mRNA. These results suggest that the induction of IGFBP-5 by
PTH is both PKA and PKC dependent and PKC-
is the primary mediator
of the effects of PTH via the PKC pathway.
insulin-like growth factor-binding protein-5; osteoblast; protein kinase C; messenger RNA; protein kinase A
This article has been cited by other articles:
![]() |
M. S Erclik and J. Mitchell Activation of the insulin-like growth factor binding protein-5 promoter by parathyroid hormone in osteosarcoma cells requires activation of an activated protein-2 element J. Mol. Endocrinol., June 1, 2005; 34(3): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |